These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 2916627)

  • 41. Third-trimester uterine rupture associated with vaginal prostaglandin E2.
    Sawyer MM; Lipshitz J; Anderson GD; Dilts PV
    Am J Obstet Gynecol; 1981 Jul; 140(6):710-1. PubMed ID: 7258248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current technology for abortion.
    Stubblefield PG
    Curr Probl Obstet Gynecol; 1978 Dec; 2(4):3-44. PubMed ID: 12310419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Midtrimester intra-aminotic administration of prostaglandin F2alpha in combination with an hyperosmolar urea solution: effect upon plasma levels of estradiol, progesterone, and human placental lactogen (HPL).
    Sher G; Katz M
    Acta Obstet Gynecol Scand; 1978; 57(3):223-5. PubMed ID: 665164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Termination of pregnancy with 16,16-dimethyl-trans-delta2 PGE1 methyl ester vaginal suppositories: an analysis of 182 cases].
    Du MK; Ying YD; Zheng HM; Yuan YE; Zhu Y
    Shengzhi Yu Biyun; 1982 Jun; 2(2):28-31. PubMed ID: 12279680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Menses induction and second-trimester pregnancy termination using a polymeric controlled release vaginal delivery system containing (15S)15-methyl PGF2 alpha methyl ester.
    Bygdeman M; Christenssen N; Gréen K; Vesterqvist O; Roseman TJ; Tuttle ME; Spilman CH
    Contraception; 1983 Feb; 27(2):141-51. PubMed ID: 6303690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
    Brenner PF; Marrs RP; Roy S; Mishell DR
    Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Midtrimester pregnancy termination: a randomized trial of prostaglandin E2 versus concentrated oxytocin.
    Owen J; Hauth JC; Winkler CL; Gray SE
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1112-6. PubMed ID: 1384335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Letter: PGE2 as a vaginal abortifacient - diaphragm effect.
    Corson SL; Bolognese RJ
    Prostaglandins; 1975 Sep; 10(3):543-4. PubMed ID: 1197786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA; Hanson FW
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intra-amniotic prostaglandin F2alpha and urea for midtrimester abortion.
    Wellman L; Jacobson A
    Fertil Steril; 1976 Dec; 27(12):1374-9. PubMed ID: 1001522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
    Kent DR; Goldstein AI; Linzey EM
    J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of two prostaglandins used to terminate midtrimester pregnancy.
    Gookin KS; White CK; Whitworth NS; Wiser WL; Morrison JC
    South Med J; 1984 Jun; 77(6):717-8, 721. PubMed ID: 6587588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mid-trimester abortion using hypertonic saline or prostaglandin E2 gel: an analysis of efficacy and complications.
    Herabutya Y; O-Prasertsawat P
    J Med Assoc Thai; 1994 Mar; 77(3):148-52. PubMed ID: 7798849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of fetal demise in advanced pregnancy terminations: report on a funic potassium chloride protocol.
    Gill P; Cyr D; Afrakhtah M; Mack L; Easterling T
    Fetal Diagn Ther; 1994; 9(4):278-82. PubMed ID: 7945911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Termination of second trimester pregnancy by intramuscular injection of 16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methyl sulphonylamide.
    Int J Gynaecol Obstet; 1982 Oct; 20(5):383-6. PubMed ID: 6128270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Midtrimester pregnancy termination by intravaginal administration of prostaglandin E2.
    Surrago EJ; Robins J
    Contraception; 1982 Sep; 26(3):285-94. PubMed ID: 6756775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of gemeprost vaginal pessaries in the termination of abnormal intra-uterine pregnancies at twelve teaching hospitals in Indonesia.
    Agoestina T; Sastrawinata S; Gonta P; Sanusi S
    J Obstet Gynaecol (Lahore); 1988; 8(3):214-8. PubMed ID: 12342311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of prostaglandin, hypertonic saline and oxytocin for second-trimester abortion.
    Muzsnai D; Kerenyi T
    Eur J Obstet Gynecol Reprod Biol; 1979 Dec; 9(6):385-9. PubMed ID: 299462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and acceptability of 15(S)-15-methyl-prostaglandin E2-methyl ester for midtrimester pregnancy termination.
    Bieniarz J; Hunter G; Scommegna A
    Am J Obstet Gynecol; 1974 Nov; 120(6):840-3. PubMed ID: 4429095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.